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Article

The Type and Frequency of Fetal
Renal Disorders and Management
of Renal Pelvis Dilatation
Jeffrey M. Dicke, MD, Valerie M. Blanco, Yan Yan, MD, Douglas E. Coplen, MD

Objective. This study describes the frequency of sonographically detected fetal renal disorders, the
correlation of fetal renal pelvis dilatation (RPD) with the need for postnatal surgery, and proposed management of RPD. Methods. The study population consisted of 342 fetuses with prospectively identified isolated renal abnormalities and known follow-up. Fetuses with RPD were considered separately
with respect to underlying renal disease, postnatal testing, and the need for surgical correction.
Obstructive RPD was defined as the need for surgical treatment. Nonobstructive RPD included those
cases that required no therapy. The correlation between prenatal RPD and the need for postnatal evaluation was examined. Results. Renal pelvis dilatation was the primary postnatal sonographic finding
in 66.4% of cases. The remainder were distributed between multicystic dysplastic kidney, duplication
malformations, and reflux, with a smaller number of other diagnoses. Renal pelvis dilatation in the
obstructive group was significantly greater than in the nonobstructive group. However, 10% of fetuses with maximum RPD of 10 mm or less had an obstructive process, whereas 58% of fetuses with
RPD of greater than 10 mm did not have obstruction. There were no cases in which preterm delivery
was necessitated by RPD. Conclusions. Renal pelvis dilatation is the most common fetal renal abnormality. The greater the RPD, the more likely it is due to obstruction. However, the overlap between
obstruction and no obstruction dictates postnatal evaluation. In that RPD, regardless of degree, did not
change the timing of delivery, a single follow-up sonographic examination either late in pregnancy or
after delivery is considered adequate for follow-up of RPD detected earlier in pregnancy. Key words:
fetal; nonobstructive; obstructive; renal pelvis dilatation.
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NMU, nonobstructed megaureter; NOH, nonobstructive
hydronephrosis; NOR, normal; OMU, obstructed
megaureter; RPD, renal pelvis dilatation; UPJ, ureteropelvic junction; VCUG, voiding cystourethrogram
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R

enal disorders are among the most common
sonographically detected fetal abnormalities.1,2
Commonly accepted thresholds for pathologic
renal pelvis dilatation (RPD) requiring further
prenatal or postnatal evaluation are an anteroposterior
measurement of the renal pelvis of 4 mm or greater at less
than 33 weeks’ gestation or 7 mm or greater at more than
33 weeks’ gestation.3 The appropriate prenatal and postnatal follow-up of fetuses exceeding these thresholds is
not standardized. This report describes the types and frequencies of isolated fetal renal abnormalities, the utility
of renal pelvis measurements in the discrimination of
obstructive versus nonobstructive disorders, proposed
prenatal management, and postnatal evaluation.
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Materials and Methods
The study population consisted of all fetuses
examined in the ultrasound unit at this institution
with isolated renal abnormalities and known
postnatal follow-up in the Department of Urology
at St Louis Children’s Hospital. The parameters
evaluated during the sonographic examination
were those recommended by the AIUM Practice
Guideline for the Performance of an Antepartum
Obstetric Ultrasound Examination.4 In addition,
fetuses were routinely evaluated for the presence
of sonographic markers for fetal aneuploidy
(nuchal skin fold thickness, hyperechoic bowel,
echogenic intracardiac focus, biparietal diameter–femur length ratio, and pyelectasis). Imaging of
the cardiac outflow tracts, upper lip, and digits was
also performed when possible. All prenatal data
were prospectively collected and retrospectively
identified from our obstetric sonography database.
The study period was from 1990 to 2004. Renal
pelvis dilatation was defined as a renal pelvis measurement of 4 mm or greater in the anteroposterior diameter at less than 33 weeks’ gestation or 7
mm or greater at more than 33 weeks’ gestation.
Statistical analysis of the differences in RPD
between obstructive and nonobstructive RPD has
been described in a prior publication.5 Postnatal
follow-up ranged from 3 months to 10 years.
For purposes of this analysis, nonobstructive
disorders were those that either resolved spontaneously postnatally or remained stable and
did not require surgical correction. These
included nonobstructive hydronephrosis
(NOH), nonobstructed megaureter (NMU),
and those cases in which the postnatal sonographic findings were deemed normal (NOR).
Obstructive lesions were those requiring surgical treatment because of decreasing renal
function, increasing hydronephrosis, or symptomatic renal colic and consisted of ureteropelvic junction (UPJ) obstruction and obstructed
megaureter (OMU).

Results
The study population consisted of 342 fetuses
between 18 and 41 weeks’ gestation. The types
and frequencies of postnatal diagnoses are listed
in Table 1. In total, 66.4% of cases involved RPD
as the primary sonographic finding. The total
number of fetuses in the nonobstructive group
was 167. There were 60 fetuses in the obstructive
974

Table 1. Postnatal Diagnoses of Sonographically
Detected Fetal Renal Abnormalities (n = 342)
Abnormality

n (%)

Nonobstructive RPD
NOH
NMU
NOR
Obstructive RPD
UPJ obstruction
OMU
Multicystic dysplastic kidney
Duplication malformations
Reflux
Other

139 (40.6)
21 (6.1)
7 (2.0)
54
6
36
32
28
19

(15.8)
(1.8)
(10.5)
(9.4)
(8.2)
(5.6)

group. The remaining cases were fairly evenly
distributed between multicystic dysplastic kidney, urinary tract duplication malformations,
and reflux. The Other category included cases of
bladder outlet obstruction, prune belly, pelvic
kidney, horseshoe kidney, and bladder exstrophy.
The mean RPD ± SD in nonobstructive diagnoses
was 11.4 ± 6.6 mm versus 23.2 ± 12.1 mm in
obstructive processes (P < .0001). The area under
the receiver operating characteristic curve was
0.800, reflecting the probability that a given magnitude of RPD is indicative of obstruction.5 All
fetuses with RPD identified prenatally had postnatal sonography as their initial evaluation. A
voiding cystourethrogram (VCUG) and renal
scintigraphy were performed at the discretion of
the pediatric urologists. The results of such testing are depicted in Tables 2 and 3. Voiding cystourethrography and renal scintigraphy testing
were performed in 95.0% and 91.7%, respectively,
of fetuses with obstructive RPD. The VCUG
revealed vesicoureteral reflux in 22.8%, and the
renal perfusion scan revealed urinary stasis (t 1/2 >
10 minutes) in 96.4%. In fetuses with nonobstructive RPD, a VCUG was obtained in 74.3% and

Table 2. VCUG Testing and Results in Obstructive
and Nonobstructive Fetal RPD (n = 227)
RPD

VCUG, n (%)

Obstructive (n = 60)
UPJ obstruction (n = 54)
OMU (n = 6)
Nonobstructive (n = 167)
NOH (n = 139)
NMU (n = 21)
NOR (n = 7)

No
3/60 (5.0)
Yes
57/60 (95.0)
Normal
44/57 (77.2)
Abnormal 13/57 (22.8)
No
43/167 (25.7)
Yes
124/167 (74.3)
Normal
119/124 (96.0)
Abnormal
5/124 (4.0)
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revealed reflux in only 4%. In the 29.3% that had
renal scintigraphy, urinary stasis was present in
49.0%. Function of the affected moiety was
reduced in less than 5% of infants.
Fetal sex was male in 76.6% of cases in the
nonobstructive group and 70.0% in the obstructive group. The fetal left kidney was slightly more
commonly affected (53.3% in the nonobstructive
group and 58.3% in the obstructive group).
The relationship between maximum RPD and
likelihood of an obstructive versus a nonobstructive process is indicated in Table 4. Of the
227 fetuses with RPD as the primary renal finding, nearly half had measurements between 4
and 10 mm. Of these, approximately 10% were
secondary to an obstructive process. In fetuses
with an RPD of 11 to 20 mm, 26.7% ultimately
required surgery. The need for surgical correction increased to nearly 70% when the RPD was
greater than 20 mm. Collectively, the ratio of
obstructive to nonobstructive disorders was
approximately 1:3.
The maximum RPD in obstructive and nonobstructive processes is indicated in Table 5.
Although there was generally a direct relationship
between RPD and renal obstruction, there was
considerable overlap with the nonobstructive
group, especially when the RPD was less than 20
mm. The numbers of fetuses requiring surgery
with mild, moderate, and severe RPD are depicted in Table 6. No fetus with a maximum RPD of
less than 6 mm required postnatal surgery. Eleven
fetuses (18% of cases requiring surgery) with RPD
between 6 and 10 mm had surgery.

Discussion
The finding of any fetal abnormality on prenatal
sonography often generates parental anxiety.6
Fetal renal disorders are among the most common malformations detected sonographically.1,2
Table 3. Renal Scintigraphy Testing and Results in
Obstructive and Nonobstructive Fetal RPD (n = 227)
RPD

Renal Scan, n (%)

Obstructive (n = 60)
No
5/60 (8.3)
UPJ obstruction (n = 54) Yes
55/60 (91.7)
OMU (n = 6)
Normal
2/55 (3.6)
Abnormal 53/55 (96.4)
Nonobstructive (n = 167) No
118/167 (70.7)
NOH (n = 139)
Yes
49/167 (29.3)
NMU (n = 21)
Normal
25/49 (51.0)
NOR (n = 7)
Abnormal 24/49 (49.0)
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The fetal renal pelves are readily visualized sonographically. The structure of the fetal kidneys and
measurement of the renal pelves are able to be
reliably assessed.7,8 This report describes the spectrum of fetal renal disorders encountered in a
tertiary care facility and examines the utility of
thresholds for RPD sufficient to warrant postnatal
evaluation. The classification of the postnatal
diagnoses as obstructive or nonobstructive was
chosen because this reflects the need for surgical
correction, an important distinction when counseling parents regarding postnatal prognosis and
management.9
Although the definition of obstruction is widely debated,10,11 we tried, to the best of our ability,
to treat all infants in the same fashion and use
the same indications for surgery in all cases. We
chose to define renal obstruction as a serial
increase in hydronephrosis on postnatal sonography, declining function on renal scintigraphy,
or symptomatic renal colic. We specifically did
not base this on renal drainage times or the magnitude of dilatation because some infants had
prolonged drainage times on renal scintigraphy
(t 1/2 > 20 minutes), but dilatation resolved with
follow-up, indicating that substantial obstruction was not present. Our results and conclusions may not be directly transferable to other
institutions. For example, if a surgeon has a more
aggressive approach that is based on sonographic appearance alone or on renal scan drainage
time, then a lower magnitude of maximum RPD
would be indicative of obstruction.
The patient whose fetus has isolated RPD may
be reasonably counseled prenatally that the likelihood of an obstructive uropathy requiring correction is low (10%) with mild RPD (4–10 mm).
This represented half of our cases. This risk
increases to nearly 70% when RPD is greater than
20 mm. The importance of postnatal follow-up
for definitive determination of clinical importance is shown by the postnatal finding that
40.7% of what were found to be nonobstructive
Table 4. Maximum Prenatal RPD and Likelihood of a Postnatal
Obstructive or Nonobstructive Process
Maximum RPD

Obstructive,
n (%)

Nonobstructive,
n (%)

Total,
n (%)

4–10 mm (n = 110)
11–20 mm (n = 75)
>20 mm (n = 42)
∑ 227

11/110 (10.0)
20/75 (26.7)
29/42 (69.0)
60/227 (26.4)

99/110 (90.0)
55/75 (73.3)
13/42 (31.0)
167/227 (73.6)

110/227 (48.5)
75/227 (33.0)
42/227 (18.5)
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Table 5. Fetal RPD in Postnatal Obstructive and Nonobstructive
Processes
RPD
Diagnosis

4–10 mm

Nonobstructive (n = 167), n (%)
NOH (n = 139)
NMU (n = 21)
NOR (n = 7)
∑
Obstructive (n = 60), n (%)
UPJ (n = 54)
OMU (n = 6)
∑

11–20 mm

>20 mm

84 (60.4)
44 (31.7)
11 (8.0)
9 (42.9)
10 (47.6)
2 (9.5)
6 (85.7)
1 (14.3)
0
99/167 (59.3) 55/167 (32.3) 13/167 (7.8)
10/54 (18.5)
1/6 (14.3)
11/60 (18.3)

19/54 (35.2)
1/6 (14.3)
20/60 (33.3)

25/54 (46.3)
4/6 (66.7)
29/60 (48.3)

processes had RPD of greater than 10 mm,
whereas 18% of obstructive lesions had prenatal
maximum RPD of 4 to 10 mm.
Renal dilatation may also be indicative of vesicoureteral reflux. We identified reflux in nearly
10% of the tested children. Although there does
not appear to be a relationship between the magnitude of RPD and the presence of reflux, there
was a trend that infants with obstruction had a
higher incidence of reflux (22% vs 4%). The clinical relevance of this reflux is unknown. Much of
this reflux is coexisting and is not thought to be
the primary disease in these children. Most of this
reflux resolves without need for surgical intervention or development of infectious complications
while the patient receives prophylaxis.5
Regardless of the maximum RPD, there were
no cases in which isolated RPD necessitated
preterm delivery. This information is useful in
counseling parents and guiding prenatal management. Once RPD is detected, serial prenatal
sonographic monitoring is probably unnecessary. A single follow-up sonographic examination late in pregnancy will allow determination of
Table 6. Maximum RPD in Fetuses Requiring
Postnatal Surgery (n = 60)
RPD, mm

4
5
6
7
8
9
10
∑, n (%)
11–20, n (%)
>20, n (%)

976

Fetuses Requiring Surgery

0
0
2
2
2
3
2
11 (18.3)
20 (33.3)
29 (48.3)

the need for postnatal follow-up. Alternatively,
postnatal sonography could be performed rather
than additional prenatal studies. This would
allow definitive renal assessment, and if the findings are normal, the total number of sonographic examinations would be no different than if a
third-trimester sonographic examination was
performed.
Conclusive recommendations regarding
appropriate postnatal follow-up cannot be
determined from this study. We recommend prophylactic antibiotics in all female infants with
RPD, in male infants with bilateral RPD that is
suggestive of reflux or bladder outlet obstruction,
and in infants with duplication anomalies pending the initial urologic evaluation at 1 month of
age. Because obstruction is very unlikely when
RPD is less than 10 mm, we do not obtain scintigraphy unless there is diffuse calycectasis or cortical thinning on the postnatal sonography.
A small number of these children had vesicoureteral reflux, and much of the detected reflux
may be clinically unimportant. The magnitude of
RPD is not predictive of reflux. Because the incidence of infection is much higher in female
infants, we currently recommend a VCUG in all
female infants with RPD but limit testing in male
infants to those with poor corticomedullary differentiation and the appearance of dysplasia
because pelvic dilatation, calyceal dilatation, and
ureterectasis do not increase the chance of highgrade reflux.12 A prospective trial is indicated to
evaluate the incidence and importance of this
reflux. Hopefully this will allow us to better define
a subset that should have a VCUG.
In summary, this report describes the types and
frequencies of isolated renal abnormalities
detected in a referral prenatal ultrasound unit.
Two thirds of cases involved RPD as the primary
sonographic finding. The degree of RPD can be
useful in prenatal counseling, although postnatal
evaluation is warranted to accurately assess the
presence or absence of obstruction. The absence
of an effect on the timing or route of delivery suggests that a conservative approach to prenatal
sonographic monitoring is appropriate.
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